Merck
CN
HomeServicesProduct ServicesEmprove® ProgramEmprove® Filters and Single-Use Components

Emprove® Filters and Single-Use Components

Information is crucial for drug manufacturers selecting filtration and single-use technologies. Answering the industry-wide demand for increasing levels of transparency, our expanded Emprove® Filter and Single-use Components portfolio now covers all the major steps of the biopharmaceutical process. So you can move forward in your product development with confidence.

Subscribe to Emprove® Suite


Emprove® Dossier Library for Filters and Single-use Components

All our high-quality portfolio products feature Emprove® Dossiers, providing the optimized information you need to fast track your drug to market. These include:

Emprove® Filtration and Single-use Component Product Groups*

For an overview of our portfolio products and dossier availability, select any product family below.

*Status as per Q1 2021, constantly updated.

Fast track your extractables risk assessment

All polymeric components, such as the filters and single-use systems used in biopharmaceutical manufacturing, must be assessed for safety through an evaluation of extractables and potential leachables. Extractables are compounds that can be extracted from these materials, while leachables are compounds that leach from the materials into the process stream. An understanding of extractables is essential as it can help identify the leachables that may enter a process stream.

With our Emprove® Program, developing an extractables profile for filters and single-use systems no longer requires a time- and resource-intensive compilation of a vast amount of data. Instead, our Emprove® Operational Excellence Dossiers provide you with reliable extractables data based on industry standards and guidelines established by the BioPhorum Operations Group's (BPOG) standardized testing protocol and USP <665> draft chapters. The datasets generated facilitate your safety risk assessment, accelerating your ability to identify potential leachables and calculate patient exposure based on process conditions, total surface area in contact with the product, batch size and final drug product maximum daily dose.

A full spectrum of services for extractables and leachables risk assessment

Together with our BioReliance® Validation Services experts, we provide a higher level of confidence in safety risk assessment through careful selection of well-characterized materials, experience in identifying and analyzing potential leachables (or process-specific extractables) data, and expertise in the design and execution of need-based leachables studies. Because every product and process is unique, we tailor our approach to deliver best-in-class services and robust results that meet global industry standards, even as the standards continue to evolve.

Emprove® Operational Excellence Dossiers by Product Family

A thorough interpretation of the extractables datasets from our Operational Excellence Dossiers to your specific product and process can further be supported through consultation and services from Bioreliance® Validation Services. For an overview of available Operational Excellence Dossiers, select any product family below.

* P/N stands for part number. The indicated part numbers are generic for the family. Please replace your specific part numbers as applicable.

Emprove® Suite: 24/7 online access to all our dossiers

Unlock all the benefits of the Emprove® Filter and Single-use Component portfolio by subscribing to our Emprove® Suite. Available exclusively for subscribers, all dossiers of the entire Emprove® portfolio can be accessed at your convenience.

  • Subscriptions of one, two, or five years
  • 24/7 online access
  • Constantly updated
  • Optimized searches

Related Product Resources




To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?